Showing results (511-520 of 536) with videos related to
Sort By:
Pageof 54
AIDS (London, England)|October 6, 2018
Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infectionLorna Leal, Alberto C Guardo, Sara Morón-López, et al.Plos One|August 9, 2019
Novel association of five HLA alleles with HIV-1 progression in Spanish long-term non progressor patientsEva Ramírez de Arellano, Francisco Díez-Fuertes, Francisco Aguilar, et al.Plos One|April 11, 2018
Correction: Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunizationAlberto C Guardo, Carmen Elena Gómez, Vicens Díaz-Brito, et al.Plos One|October 25, 2017
Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunizationAlberto C Guardo, Carmen Elena Gómez, Vicens Díaz-Brito, et al.The Lancet Regional Health. Europe|April 19, 2021
Trends in mortality of hospitalised COVID-19 patients: A single centre observational cohort study from SpainCarolina Garcia-Vidal, Alberto Cózar-Llistó, Fernanda Meira, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 2, 2026
TIME TO POSITIVITY AS A DIAGNOSTIC TOOL FOR CATHETER-RELATED CANDIDEMIA: A SPECIES-SPECIFIC ANALYSISMarta Albanell-Fernández, Andrea Vergara, Celia Cardozo, et al.The Journal of Infection|June 16, 2026
DEFINING THE THRESHOLD DURATION OF CANDIDEMIA ASSOCIATED WITH POOR OUTCOMES: REDEFINING PERSISTENT CANDIDEMIAMarta Albanell-Fernández, Andrea Vergara, Celia Cardozo, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 4, 2020
Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort studyCarolina Garcia-Vidal, Gemma Sanjuan, Estela Moreno-García, et al.Retrovirology|November 11, 2017
The HIV-1 integrase-LEDGF allosteric inhibitor MUT-A: resistance profile, impairment of virus maturation and infectivity but without influence on RNA packaging or virus immunoreactivityCéline Amadori, Yme Ubeles van der Velden, Damien Bonnard, et al.Nature Communications|February 5, 2025
Optical time-lapsed in situ mechanochemical studies on metal halide perovskite systemsYonghao Xiao, David G Bradley, Wei Xin Chan, et al.Pageof 54